Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP527953.RA4SdSPe-ChX5kHi4szILWwyEizpc7Y9cadV2RjtTNzGs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP527953.RA4SdSPe-ChX5kHi4szILWwyEizpc7Y9cadV2RjtTNzGs130_assertion type Assertion NP527953.RA4SdSPe-ChX5kHi4szILWwyEizpc7Y9cadV2RjtTNzGs130_head.
- NP527953.RA4SdSPe-ChX5kHi4szILWwyEizpc7Y9cadV2RjtTNzGs130_assertion description "[Previously, we have shown that dual inhibition of EGFR and MEK signaling shows a synergistic effect on KRAS mutant gastric cancer cells by suppressing compensatory activation of AKT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527953.RA4SdSPe-ChX5kHi4szILWwyEizpc7Y9cadV2RjtTNzGs130_provenance.
- NP527953.RA4SdSPe-ChX5kHi4szILWwyEizpc7Y9cadV2RjtTNzGs130_assertion evidence source_evidence_literature NP527953.RA4SdSPe-ChX5kHi4szILWwyEizpc7Y9cadV2RjtTNzGs130_provenance.
- NP527953.RA4SdSPe-ChX5kHi4szILWwyEizpc7Y9cadV2RjtTNzGs130_assertion SIO_000772 20358631 NP527953.RA4SdSPe-ChX5kHi4szILWwyEizpc7Y9cadV2RjtTNzGs130_provenance.
- NP527953.RA4SdSPe-ChX5kHi4szILWwyEizpc7Y9cadV2RjtTNzGs130_assertion wasDerivedFrom befree-20150227 NP527953.RA4SdSPe-ChX5kHi4szILWwyEizpc7Y9cadV2RjtTNzGs130_provenance.
- NP527953.RA4SdSPe-ChX5kHi4szILWwyEizpc7Y9cadV2RjtTNzGs130_assertion wasGeneratedBy ECO_0000203 NP527953.RA4SdSPe-ChX5kHi4szILWwyEizpc7Y9cadV2RjtTNzGs130_provenance.